Trials / Completed
CompletedNCT00874484
Enoxaparin as Treatment for Vulvodynia
Enoxaparin as Treatment for Vulvar Vestibulitis Syndrome - Vulvodynia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Western Galilee Hospital-Nahariya · Other Government
- Sex
- Female
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The investigators hypothesize that injections of Low molecular weight heparin (LMWH) \[enoxaparin\] will reduce pain in women with vulvodynia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clexane (enoxaparin) | One arm receives enoxoparin, second arm receives saline |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2011-04-01
- Completion
- 2011-05-01
- First posted
- 2009-04-02
- Last updated
- 2020-05-20
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00874484. Inclusion in this directory is not an endorsement.